5th Annual Ophthalmic Drug Delivery Summit

5th Annual Ophthalmic Drug Delivery Summit is organized by Hanson Wade and will be held from Jan 19 - 21, 2027 at Hyatt Centric Fisherman's Wharf San Francisco, San Francisco, California, United States of America.

Description:
Advancing Novel, Durable, & Effective Ocular Drug Delivery Systems Whilst Improving Patient Adherence, Overcoming Regulatory Hurdles & Addressing Critical Unmet Medical Needs
The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the right place in the eye.

Hear directly from leaders at Kodiak Sciences, Re-Vana Therapeutics, Ripple Therapeutics, Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Beacon Therapeutics, Kriya Therapeutics and more as they share the latest thinking on long-acting therapies, novel delivery routes, gene and cell therapy, translational science and drug-device integration.

With clinical validation and investment accelerating across the field, this industry-focused, modality and indication-agnostic meeting offers a timely opportunity to benchmark emerging technologies, learn from development successes and setbacks, and connect with the experts tackling the biggest barriers to effective ocular delivery. 

Explore the Full Event Guide:

• 3 days of cutting-edge ophthalmic drug delivery content 
• 3 interactive pre-conference workshops
• Long-acting, gene & cell therapy, topical, implantable & suprachoroidal delivery
• Insights from leaders at Eli Lilly, Genentech, Sanofi, Astellas & more
• Speed networking, roundtables, panels and poster sessions designed for meaningful industry connection